BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -1.49% -14.47% -20.30% -6.07% -4.31% -1.10% -4.38% -4.22% 13.18% 04/07/2010
BIB NAV -1.28% -14.31% -20.40% -5.95% -4.14% -1.07% -4.38% -4.22% 13.19% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 5/14/2025
  • NAV
    $39.76
  • NAV Change
    $-1.63 down caret
  • Market Price
    $39.84
  • Market Price Change
    $-1.64 down caret
  • Trading Volume (M)
    12,417
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 5/14/2025
  • NAV
    $39.76
  • NAV Change
    $-1.63 down caret
  • Market Price
    $39.84
  • Market Price Change
    $-1.64 down caret
  • Trading Volume (M)
    12,417
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2025

Holdings

as of 5/13/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
6.24% VRTX VERTEX PHARMACEUTICALS INC -- $2,740,176.00 6,343 2931034
6.15% GILD GILEAD SCIENCES INC -- $2,700,370.89 26,623 2369174
6.09% AMGN AMGEN INC -- $2,671,775.55 9,879 2023607
5.34% REGN REGENERON PHARMACEUTICALS -- $2,343,146.96 4,081 2730190
3.41% AZN ASTRAZENECA PLC-SPONS ADR -- $1,496,612.00 22,100 2989044
2.99% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,311,083.18 4,913 B00FWN1
1.57% SMMT SUMMIT THERAPEUTICS INC -- $689,006.17 27,997 BMTVQS7
1.56% BIIB BIOGEN INC -- $684,030.64 5,554 2455965
1.50% ARGX ARGENX SE - ADR -- $659,101.05 1,215 BDVLM39
1.24% SNY SANOFI-ADR -- $544,863.76 10,906 2964557
1.23% RPRX ROYALTY PHARMA PLC- CL A -- $539,757.72 16,446 BMVP7Y0
1.20% UTHR UNITED THERAPEUTICS CORP -- $524,951.28 1,704 2430412
1.10% ILMN ILLUMINA INC -- $482,683.30 6,011 2613990
1.03% INSM INSMED INC -- $451,361.99 6,869 2614487
1.02% INCY INCYTE CORP -- $446,649.45 7,345 2471950
1.01% NBIX NEUROCRINE BIOSCIENCES INC -- $442,352.95 3,785 2623911
1.00% TEM TEMPUS AI INC -- $437,233.95 6,345 BSLSJJ0
0.99% BMRN BIOMARIN PHARMACEUTICAL INC -- $432,807.20 7,240 2437071
0.91% VTRS VIATRIS INC -- $398,222.16 45,304 BMWS3X9
0.89% EXEL EXELIXIS INC -- $392,445.95 10,621 2576941
0.85% MRNA MODERNA INC -- $373,224.58 14,642 BGSXTS3
0.84% ASND ASCENDIS PHARMA A/S - ADR -- $370,203.84 2,292 BV9G6B8
0.82% MEDP MEDPACE HOLDINGS INC -- $358,843.55 1,157 BDCBC61
0.81% ONC BEIGENE LTD-ADR -- $357,095.97 1,589 BYYWPW6
0.81% BNTX BIONTECH SE-ADR -- $356,926.50 3,777 BK6H543
0.66% ROIV ROIVANT SCIENCES LTD -- $291,391.56 27,081 BMW4NZ9
0.64% RVMD REVOLUTION MEDICINES INC -- $281,927.15 7,057 BL71K91
0.56% MDGL MADRIGAL PHARMACEUTICALS INC -- $247,511.68 838 BD59BS7
0.55% BPMC BLUEPRINT MEDICINES CORP -- $241,156.53 2,426 BWY52P3
0.55% BBIO BRIDGEBIO PHARMA INC -- $240,070.68 7,218 BK1KWG8
0.54% JAZZ JAZZ PHARMACEUTICALS PLC -- $237,104.64 2,304 B4Q5ZN4
0.54% HALO HALOZYME THERAPEUTICS INC -- $234,775.02 4,674 2975098
0.46% VRNA VERONA PHARMA PLC - ADR -- $202,034.30 2,990 BYWPZK5
0.45% IONS IONIS PHARMACEUTICALS INC -- $196,253.49 6,033 BDJ0LS6
0.45% AXSM AXSOME THERAPEUTICS INC -- $195,383.83 1,849 BYZR4X4
0.44% GH GUARDANT HEALTH INC -- $193,730.24 4,684 BFXC911
0.43% ALKS ALKERMES PLC -- $190,313.64 6,171 B3P6D26
0.41% NUVL NUVALENT INC-A -- $179,335.62 2,511 BMVBZD3
0.41% ADMA ADMA BIOLOGICS INC -- $178,343.48 8,971 B9NSBM2
0.34% KRYS KRYSTAL BIOTECH INC -- $147,175.82 1,094 BD6JX35
0.33% PCVX VAXCYTE INC -- $146,854.35 4,887 BKPVGH6
0.32% PTCT PTC THERAPEUTICS INC -- $138,845.27 2,993 B17VCN9
0.31% CYTK CYTOKINETICS INC -- $137,530.73 4,493 BBBSBJ5
0.31% RNA AVIDITY BIOSCIENCES INC -- $136,342.44 4,563 BMWHPY1
0.31% RYTM RHYTHM PHARMACEUTICALS INC -- $136,239.21 2,399 BF2YWG4
0.30% SRPT SAREPTA THERAPEUTICS INC -- $133,324.60 3,683 B8DPDT7
0.30% SWTX SPRINGWORKS THERAPEUTICS INC -- $131,449.68 2,844 BGMGM89
0.28% RARE ULTRAGENYX PHARMACEUTICAL IN -- $124,254.00 3,510 BJ62Z18
0.28% ACLX ARCELLX INC -- $121,393.00 2,084 BPCJ1Q2
0.28% CRSP CRISPR THERAPEUTICS AG -- $121,188.32 3,256 BDHF4K6
0.28% AKRO AKERO THERAPEUTICS INC -- $120,910.22 3,022 BK7Y2V9
0.28% ALVO ALVOTECH SA -- $120,816.96 11,441 BPNTJ34
0.26% SRRK SCHOLAR ROCK HOLDING CORP -- $112,788.80 3,592 BFZQ0L8
0.25% CRNX CRINETICS PHARMACEUTICALS IN -- $109,315.40 3,532 BDD19F8
0.25% ACAD ACADIA PHARMACEUTICALS INC -- $108,858.80 6,329 2713317
0.24% MRUS MERUS NV -- $107,333.16 2,623 BZBY005
0.23% PTGX PROTAGONIST THERAPEUTICS INC -- $103,104.83 2,329 BDCBCD8
0.22% LEGN LEGEND BIOTECH CORP-ADR -- $96,379.08 3,101 BMX9K07
0.21% IMVT IMMUNOVANT INC -- $90,400.96 6,448 BJRFSB7
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $88,230.00 11,764 BFNF1D6
0.20% VCYT VERACYTE INC -- $86,669.67 2,957 BFTWZY0
0.20% XENE XENON PHARMACEUTICALS INC -- $86,017.60 2,906 BRJ3GY4
0.19% MIRM MIRUM PHARMACEUTICALS INC -- $84,156.93 1,859 BJDX8Y8
0.19% VCEL VERICEL CORP -- $82,785.08 1,897 BSBMN89
0.19% APLS APELLIS PHARMACEUTICALS INC -- $82,321.92 4,764 BYTQ6X1
0.18% BCRX BIOCRYST PHARMACEUTICALS INC -- $79,785.86 7,931 2100362
0.18% DNLI DENALI THERAPEUTICS INC -- $78,586.86 5,511 BD2B4V0
0.18% -- NEWAMSTERDAM PHARMA CO NV -- $78,150.00 4,168 BP8JSP4
0.18% LGND LIGAND PHARMACEUTICALS -- $77,109.90 730 2501578
0.17% KYMR KYMERA THERAPEUTICS INC -- $76,728.96 2,464 BMPRZV5
0.17% NVCR NOVOCURE LTD -- $75,680.08 4,172 BYSS4X4
0.17% HRMY HARMONY BIOSCIENCES HOLDINGS -- $74,789.12 2,176 BKSGZN7
0.17% ARWR ARROWHEAD PHARMACEUTICALS IN -- $73,145.36 4,787 BYQBFJ8
0.17% TWST TWIST BIOSCIENCE CORP -- $73,104.56 2,264 BGKG6G7
0.16% TVTX TRAVERE THERAPEUTICS INC -- $70,525.92 3,368 BLFGJD5
0.16% FOLD AMICUS THERAPEUTICS INC -- $70,199.22 11,661 B19FQ48
0.16% CGON CG ONCOLOGY INC -- $69,856.02 2,889 BRBCSP4
0.16% IBRX IMMUNITYBIO INC -- $69,559.63 27,713 BNSP0B8
0.16% SUPN SUPERNUS PHARMACEUTICALS INC -- $68,390.73 2,119 B72ZBG4
0.15% ZLAB ZAI LAB LTD-ADR -- $67,972.50 2,375 BD9GVY0
0.15% APGE APOGEE THERAPEUTICS INC -- $67,836.18 1,707 BM9HHL5
0.15% RXRX RECURSION PHARMACEUTICALS-A -- $67,622.94 14,994 BM9FJ13
0.14% AGIO AGIOS PHARMACEUTICALS INC -- $62,480.76 2,174 BCBVTX1
0.14% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $62,231.46 4,503 BKX9VD3
0.14% IRON DISC MEDICINE INC -- $60,811.20 1,312 BMGJZJ8
0.14% TARS TARSUS PHARMACEUTICALS INC -- $60,448.68 1,458 BMH5RL1
0.13% IDYA IDEAYA BIOSCIENCES INC -- $57,986.35 3,323 BK0VHF6
0.13% BEAM BEAM THERAPEUTICS INC -- $57,326.80 3,176 BK6L288
0.13% JANX JANUX THERAPEUTICS INC -- $56,789.86 2,242 BMFX8Y7
0.12% GRAL GRAIL INC -- $54,727.64 1,276 BSLSSX7
0.12% MNKD MANNKIND CORP -- $54,383.84 11,522 BF081J4
0.12% GPCR STRUCTURE THERAPEUTICS INC -- $54,015.29 2,261 BQS9486
0.12% EWTX EDGEWISE THERAPEUTICS INC -- $53,499.77 3,593 BKY5JZ8
0.12% INDV INDIVIOR PLC -- $52,727.28 4,712 BP0BQQ5
0.12% VERA VERA THERAPEUTICS INC -- $52,223.60 2,420 BL55460
0.12% ADPT ADAPTIVE BIOTECHNOLOGIES -- $52,042.58 5,602 BJ5FZ74
0.12% DYN DYNE THERAPEUTICS INC -- $51,945.30 4,293 BN15WD1
0.12% ANIP ANI PHARMACEUTICALS INC -- $51,150.00 825 BCDWBX6
0.11% SPRY ARS PHARMACEUTICALS INC -- $49,248.15 3,689 BMCR7V2
0.10% DVAX DYNAVAX TECHNOLOGIES CORP -- $45,300.58 4,709 BRJZSK0
0.10% AMPH AMPHASTAR PHARMACEUTICALS IN -- $43,604.88 1,826 BNFWZS4
0.10% INVA INNOVIVA INC -- $43,404.02 2,377 BDDXF67
0.10% ETNB 89BIO INC -- $43,219.80 5,541 BK1K484
0.10% CNTA CENTESSA PHARMACEUTICALS-ADR -- $43,173.90 3,465 BLB0YQ9
0.10% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $42,939.20 1,504 BLCD809
0.10% OCUL OCULAR THERAPEUTIX INC -- $41,762.00 5,966 BNZB1X8
0.09% PCRX PACIRA BIOSCIENCES INC -- $41,137.20 1,758 B3X26D8
0.09% KNSA KINIKSA PHARMACEUTICALS INTE -- $40,832.00 1,595 BRXB0C0
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $40,757.84 5,212 BFWLC09
0.09% TXG 10X GENOMICS INC-CLASS A -- $39,661.50 4,110 BKS3RS7
0.09% NVAX NOVAVAX INC -- $37,783.76 6,104 BJDQXG4
0.08% ELVN ENLIVEN THERAPEUTICS INC -- $37,115.59 1,853 BMFD115
0.08% WVE WAVE LIFE SCIENCES LTD -- $36,985.32 5,788 BYZG9R0
0.08% GRFS GRIFOLS SA-ADR -- $36,391.80 4,630 B8K7T65
0.08% COLL COLLEGIUM PHARMACEUTICAL INC -- $35,611.00 1,195 BX7RSN3
0.08% HROW HARROW INC -- $35,517.04 1,352 BHNDW86
0.08% SYRE SPYRE THERAPEUTICS INC -- $33,748.00 2,288 BQBBDY8
0.08% AVDL AVADEL PHARMACEUTICALS -- $33,031.74 3,658 BDGMC59
0.08% SNDX SYNDAX PHARMACEUTICALS INC -- $33,015.60 3,240 BN7Q7R7
0.07% NTLA INTELLIA THERAPEUTICS INC -- $32,697.60 3,930 BYZM6C2
0.07% GMAB GENMAB A/S -SP ADR -- $30,741.52 1,592 BBC9WC7
0.07% ARDX ARDELYX INC -- $30,665.94 9,046 BN89V40
0.07% ZYME ZYMEWORKS INC -- $30,348.54 2,614 BPCQZY9
0.07% LENZ LENZ THERAPEUTICS INC -- $30,205.28 1,043 BQV0J03
0.07% GERN GERON CORP -- $29,007.60 24,173 2370381
0.07% CVAC CUREVAC NV -- $28,901.64 8,513 BN4RD42
0.07% MLYS MINERALYS THERAPEUTICS INC -- $28,739.48 1,892 BP9N0G0
0.07% PRAX PRAXIS PRECISION MEDICINES I -- $28,587.12 766 BQ721R4
0.06% NRIX NURIX THERAPEUTICS INC -- $28,022.40 2,880 BMVLGP2
0.06% XERS XERIS BIOPHARMA HOLDINGS INC -- $27,724.20 5,658 BLR7H87
0.06% CRMD CORMEDIX INC -- $26,772.26 2,302 BJ0LT31
0.06% RCKT ROCKET PHARMACEUTICALS INC -- $26,757.68 4,045 BDFKQ07
0.06% QURE UNIQURE NV -- $26,298.93 2,053 BJFSR88
0.06% AVXL ANAVEX LIFE SCIENCES CORP -- $26,211.36 3,228 BYTYP72
0.06% VIR VIR BIOTECHNOLOGY INC -- $24,463.50 5,205 BK4PZ38
0.06% AVBP ARRIVENT BIOPHARMA INC -- $24,448.00 1,280 BMGTLY5
0.06% DAWN DAY ONE BIOPHARMACEUTICALS I -- $24,351.51 3,847 BLB0YH0
0.06% EOLS EVOLUS INC -- $24,342.39 2,403 BDRJH21
0.05% ANAB ANAPTYSBIO INC -- $23,885.28 1,164 BDRW1L7
0.05% ABCL ABCELLERA BIOLOGICS INC -- $23,748.90 11,309 BL53SR3
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $22,942.48 7,192 BZ0QMB7
0.05% IOVA IOVANCE BIOTHERAPEUTICS INC -- $22,274.76 12,444 BF0DMK7
0.05% TRVI TREVI THERAPEUTICS INC -- $21,895.36 3,392 BJH9ZN0
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $21,825.00 1,875 BD06CS0
0.05% XNCR XENCOR INC -- $21,694.25 2,675 BGCYWN8
0.05% REPL REPLIMUNE GROUP INC -- $21,659.43 2,923 BDDVW37
0.05% COGT COGENT BIOSCIENCES INC -- $21,561.79 4,321 BLR6XK8
0.05% KROS KEROS THERAPEUTICS INC -- $20,743.80 1,540 BM7V485
0.04% SVRA SAVARA INC -- $19,346.58 6,514 BYXGN81
0.04% TYRA TYRA BIOSCIENCES INC -- $19,181.56 1,922 BMVNDH9
0.04% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $19,015.80 773 BL95N25
0.04% CSTL CASTLE BIOSCIENCES INC -- $18,443.49 1,083 BKLCWZ3
0.04% RLAY RELAY THERAPEUTICS INC -- $18,211.05 6,435 BN2R582
0.04% TSHA TAYSHA GENE THERAPIES INC -- $18,207.54 7,781 BNC1BX1
0.04% STOK STOKE THERAPEUTICS INC -- $17,940.37 2,009 BJQ05Z6
0.04% KURA KURA ONCOLOGY INC -- $17,771.20 3,064 BYZD465
0.04% MNMD MIND MEDICINE MINDMED INC -- $17,727.71 2,783 BPQYY97
0.04% PSNL PERSONALIS INC -- $17,219.00 3,350 BJQ0608
0.04% FTRE FORTREA HOLDINGS INC -- $17,025.00 3,405 BRXYZ57
0.04% CGEM CULLINAN THERAPEUTICS INC -- $16,924.02 2,221 BM90J52
0.04% ALT ALTIMMUNE INC -- $16,836.48 2,923 BFY7DC4
0.04% TBPH THERAVANCE BIOPHARMA INC -- $16,626.06 1,866 BMNDK09
0.04% ARVN ARVINAS INC -- $16,416.90 2,610 BDZ30Q0
0.04% URGN UROGEN PHARMA LTD -- $16,254.42 1,603 BZ7PJQ1
0.04% SIGA SIGA TECHNOLOGIES INC -- $16,091.46 2,709 2107437
0.04% ZVRA ZEVRA THERAPEUTICS INC -- $15,944.62 2,026 BLFBZ32
0.04% PRTA PROTHENA CORP PLC -- $15,506.37 2,043 B91XRN2
0.04% HCM HUTCHMED CHINA-ADR -- $15,452.64 1,176 BYXV9H7
0.04% SAGE SAGE THERAPEUTICS INC -- $15,421.13 2,333 BP4GNK9
0.04% MESO MESOBLAST LTD- SPON ADR -- $15,387.72 1,292 BQS7491
0.04% RGNX REGENXBIO INC -- $15,378.40 1,880 BZ0G875
0.03% EYPT EYEPOINT PHARMACEUTICALS INC -- $15,312.81 2,591 BMGS7L1
0.03% MGTX MEIRAGTX HOLDINGS PLC -- $15,274.90 2,966 BFYQFJ2
0.03% SANA SANA BIOTECHNOLOGY INC -- $15,210.83 8,474 BMFJJ97
0.03% TRML TOURMALINE BIO INC -- $15,120.42 973 BQ80NC6
0.03% PGEN PRECIGEN INC -- $15,006.60 11,116 BKM5C84
0.03% GLPG GALAPAGOS NV-SPON ADR -- $14,923.04 556 B292NQ7
0.03% AMLX AMYLYX PHARMACEUTICALS INC -- $14,605.97 3,253 BPCK358
0.03% ORIC ORIC PHARMACEUTICALS INC -- $14,315.76 2,696 BKVDFF7
0.03% ERAS ERASCA INC -- $14,272.23 10,731 BNLYBF3
0.03% VERV VERVE THERAPEUTICS INC -- $14,019.20 3,370 BNKGXX2
0.03% RAPP RAPPORT THERAPEUTICS INC -- $13,866.12 1,388 BR3T9B6
0.03% ORKA ORUKA THERAPEUTICS INC -- $13,670.02 1,421 BKVF0J2
0.03% TKNO ALPHA TEKNOVA INC -- $13,635.02 2,023 BP7L561
0.03% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $13,559.92 1,672 BKDQKM6
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $13,188.24 2,818 BMZ4LN0
0.03% ABSI ABSCI CORP -- $12,902.64 4,359 BN94K69
0.03% TRDA ENTRADA THERAPEUTICS INC -- $12,414.90 1,427 BP81RK8
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $12,217.72 668 BQD3J33
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $12,180.22 1,027 BKC9SX3
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $11,951.95 10,393 B4N8MH9
0.03% TECX TECTONIC THERAPEUTIC INC -- $11,326.59 561 BPBPCG8
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $11,088.98 5,383 BMCWKZ2
0.02% ITOS ITEOS THERAPEUTICS INC -- $10,880.10 1,386 BMWXFT4
0.02% AURA AURA BIOSCIENCES INC -- $9,972.96 1,896 BP81R42
0.02% RNAC CARTESIAN THERAPEUTICS INC -- $9,832.80 964 BQB9HM8
0.02% OMER OMEROS CORP -- $9,746.00 2,200 B4NB858
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $9,659.62 7,606 BFMLGR4
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $9,487.71 2,439 BYP80F1
0.02% GLUE MONTE ROSA THERAPEUTICS INC -- $9,417.24 2,331 BP7KZP7
0.02% TERN TERNS PHARMACEUTICALS INC -- $9,346.70 3,223 BMDJ0C9
0.02% CMPS COMPASS PATHWAYS PLC -- $9,196.20 2,358 BMC3HS7
0.02% FHTX FOGHORN THERAPEUTICS INC -- $9,140.63 2,111 BMF7DT9
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $8,992.54 7,958 BFZNYB7
0.02% MXCT MAXCYTE INC -- $8,808.80 4,004 BKMQF66
0.02% VNDA VANDA PHARMACEUTICALS INC -- $8,807.74 2,213 B12W3P6
0.02% THRD THIRD HARMONIC BIO INC -- $8,801.35 1,709 BNNPQY8
0.02% NGNE NEUROGENE INC -- $8,747.64 564 BS2F741
0.02% LXRX LEXICON PHARMACEUTICALS INC -- $8,642.97 13,719 BWFZX59
0.02% PHAT PHATHOM PHARMACEUTICALS INC -- $8,592.76 2,596 BJLKVS6
0.02% HUMA HUMACYTE INC -- $8,447.59 4,883 BMYTJP4
0.02% AVIR ATEA PHARMACEUTICALS INC -- $8,434.41 3,207 BLN9Z50
0.02% ATXS ASTRIA THERAPEUTICS INC -- $8,353.80 2,142 BMYRFN8
0.02% SLDB SOLID BIOSCIENCES INC -- $8,082.63 2,897 BQHN6C7
0.02% CDXS CODEXIS INC -- $8,046.08 3,143 B5LL2C2
0.02% ALMS ALUMIS INC -- $7,987.86 1,791 BPLQG36
0.02% SLRN ACELYRIN INC -- $7,985.89 3,821 BQPF874
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $7,923.40 3,460 BYVQJ96
0.02% AMRN AMARIN CORP PLC -ADR -- $7,805.20 760 BN72KB0
0.02% TVGN TEVOGEN BIO HOLDINGS INC -- $7,705.88 6,643 BPG5P75
0.02% DSGN DESIGN THERAPEUTICS INC -- $7,675.50 2,150 BMFK3H6
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $7,332.24 1,784 BL5B6Z1
0.02% ANNX ANNEXON INC -- $7,077.00 4,044 BMVV9R5
0.02% YMAB Y-MABS THERAPEUTICS INC -- $7,067.84 1,699 BG31GH0
0.02% CRGX CARGO THERAPEUTICS INC -- $6,939.56 1,748 BQHN2F2
0.02% VYGR VOYAGER THERAPEUTICS INC -- $6,802.72 2,074 BY7RB53
0.01% OABI OMNIAB INC -- $6,430.20 4,593 BN13S71
0.01% PRME PRIME MEDICINE INC -- $6,323.33 4,979 BPBJFM7
0.01% INBX INHIBRX BIOSCIENCES INC -- $6,204.00 550 BNSP8K3
0.01% ACIU AC IMMUNE SA -- $5,892.21 3,753 BZC0D70
0.01% ESPR ESPERION THERAPEUTICS INC -- $5,838.07 7,478 BBNBTD2
0.01% FDMT 4D MOLECULAR THERAPEUTICS IN -- $5,751.93 1,759 BKLXFX5
0.01% TNGX TANGO THERAPEUTICS INC -- $5,745.60 4,104 BP2P6L0
0.01% NKTX NKARTA INC -- $5,197.26 2,679 BK80YJ8
0.01% EDIT EDITAS MEDICINE INC -- $4,699.50 3,133 BZ8FPH3
0.01% LRMR LARIMAR THERAPEUTICS INC -- $4,541.25 2,422 BMXNGZ6
0.01% FATE FATE THERAPEUTICS INC -- $4,488.00 4,488 BCZS820
0.01% LYEL LYELL IMMUNOPHARMA INC -- $4,486.61 11,089 BN6MB18
0.01% SCPH SCPHARMACEUTICALS INC -- $4,408.00 1,900 BYX2Z16
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $4,231.07 809 B9L5200
0.01% ALEC ALECTOR INC -- $4,174.71 3,761 BJ4LDC4
0.01% NMRA NEUMORA THERAPEUTICS INC -- $4,166.08 6,132 BN4JN37
0.01% IRWD IRONWOOD PHARMACEUTICALS INC -- $4,156.52 6,075 B3MZ6K5
0.01% CCCC C4 THERAPEUTICS INC -- $4,041.00 2,694 BKX9NQ0
0.01% KYTX KYVERNA THERAPEUTICS INC -- $3,797.84 1,637 BSMLR16
0.01% LXEO LEXEO THERAPEUTICS INC -- $3,684.66 1,302 BQ6C357
0.01% MGNX MACROGENICS INC -- $3,666.74 2,381 BFDV8K0
0.01% CLYM CLIMB BIO INC -- $3,238.50 2,550 BMW5LX6
0.01% PLRX PLIANT THERAPEUTICS INC -- $3,186.42 2,309 BMDWW66
0.01% PYXS PYXIS ONCOLOGY INC -- $2,685.83 2,257 BLBR8D5
0.01% INZY INOZYME PHARMA INC -- $2,658.51 2,439 BMVLGY1
0.01% STRO SUTRO BIOPHARMA INC -- $2,551.26 3,130 BF12XC2
0.01% TCRX TSCAN THERAPEUTICS INC -- $2,477.79 1,863 BNLYBJ7
0.01% BMEA BIOMEA FUSION INC -- $2,241.25 1,375 BNKF6N0
-- APLT APPLIED THERAPEUTICS INC -- $1,943.92 4,417 BJL38Z1
-- PEPG PEPGEN INC -- $1,898.73 1,241 BMTX3D7
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $1,890.10 922 BMF1LJ7
-- MRSN MERSANA THERAPEUTICS INC -- $1,679.24 4,688 BF3NP05
-- IGMS IGM BIOSCIENCES INC -- $1,488.10 1,294 BKS3SM8
-- ACRV ACRIVON THERAPEUTICS INC -- $1,334.53 1,181 BP2TPK4
-- OKUR ONKURE THERAPEUTICS INC-A -- $918.16 499 BT7KGT6
-- QTTB Q32 BIO INC -- $803.88 462 BS2FKQ4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
35.77% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 15,694,534 -- 3,930 --
25.80% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 11,321,629 -- 2,835 --
21.42% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 9,400,746 -- 2,354 --
17.47% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 7,663,565 -- 1,919 --
12.59% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 5,523,038 -- 1,383 --
11.88% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 5,211,544 -- 1,305 --
-- -- TREASURY BILL -- $7,488,530.18 7,500,000 BQC9631
-- -- TREASURY BILL -- $4,480,459.38 4,500,000 BRBYPQ0
-- -- TREASURY BILL -- $3,997,180.00 4,000,000 BSZBFQ4
-- -- TREASURY BILL -- $2,988,057.51 3,000,000 BSNQ2D7
-- -- TREASURY BILL -- $746,206.15 750,000 BS60BF1
-- -- NET OTHER ASSETS (LIABILITIES) -- $-8,916,882.84 -8,916,883 --

Index

as of 3/31/2025

  • Total Number of Companies264
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.80 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.